Equifax Machinery and equipment remained flat by 0.0% to $239.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.7%, from $232.90M to $239.30M. Over 5 years (FY 2020 to FY 2025), Machinery and equipment shows a downward trend with a -4.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
High investment in machinery suggests a focus on production capacity expansion or technological upgrades to improve product quality.
The value of production machinery, equipment, and tooling used to manufacture products. For a company like Abbott, this...
High machinery value relative to revenue is typical for capital-intensive medical technology manufacturers.
ppe_machinery| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $303.50M | $301.80M | $299.60M | $305.40M | $302.70M | $306.30M | $281.40M | $285.50M | $284.20M | $286.30M | $247.90M | $248.40M | $253.70M | $257.40M | $229.60M | $232.90M | $246.90M | $244.70M | $239.30M | $239.30M |
| QoQ Change | — | -0.6% | -0.7% | +1.9% | -0.9% | +1.2% | -8.1% | +1.5% | -0.5% | +0.7% | -13.4% | +0.2% | +2.1% | +1.5% | -10.8% | +1.4% | +6.0% | -0.9% | -2.2% | +0.0% |
| YoY Change | — | — | — | — | -0.3% | +1.5% | -6.1% | -6.5% | -6.1% | -6.5% | -11.9% | -13.0% | -10.7% | -10.1% | -7.4% | -6.2% | -2.7% | -4.9% | +4.2% | +2.7% |
| % of PP&E (Net) | 25.0% | 24.1% | 22.8% | 22.1% | 21.1% | 20.6% | 17.7% | 17.3% | 16.5% | 16.2% | 13.5% | 13.4% | 13.5% | 13.4% | 12.1% | 12.3% | 12.9% | 12.8% | 12.4% | 12.4% |
| Share Change | — | -0.9pp | -1.3pp | -0.7pp | -1.0pp | -0.5pp | -2.9pp | -0.5pp | -0.8pp | -0.3pp | -2.7pp | -0.1pp | +0.0pp | -0.0pp | -1.3pp | +0.2pp | +0.6pp | -0.1pp | -0.4pp | +0.0pp |